Page 1 of Clinical Trials for Drug Delayed and extended release mesalazine, 3 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Safety and Efficacy of SPD476 (Mesalazine) Given Twice Daily (2.4 g/Day) vs SPD476 Given as a Single Dose (4.8 g/Day) in Subjects With Acute Mild to Moderate Ulcerative Colitis
Last Updated: June 26, 2009
Condition(s): Colitis, Ulcerative
2
Completed
Efficacy and Safety of Two Doses of SPD476 (Mesalazine) 2.4g and 4.8g Once Daily, With Reference to Asacol 0.8g Three Times Daily in Subjects With Acute, Mild to Moderate Ulcerative Colitis
Last Updated: May 5, 2009
Condition(s): Ulcerative Colitis
3
Completed
Phase II Dose-Ranging Study in Subjects With Mild to Moderate Ulcerative Colitis Treated With SPD476
Last Updated: June 18, 2009
Condition(s): Colitis, Ulcerative

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Delayed+and+extended+release+mesalazine

Page 1 of Clinical Trials for Drug Delayed and extended release mesalazine, 3 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About